BIO-Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
CT
Cellula Therapeutics at BIO-Europe 2026
Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website
Cellula Therapeutics takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its sessions centre on clinical strategy and funding, covering how to plan the development of rare disease therapeutics and how mission-driven capital can back therapies outside traditional venture models. The rare disease session is shared with Allinky Biopharma and Gibela Therapeutics.
| Organization | BIO-Europe 2026 Attendance |
|---|---|
CT Cellula Therapeutics Epalinges, Switzerland | |
Swiss cell therapy biotech spun out of the University of Geneva. | Panel Wed Nov 11 10:30–10:55 Building a Clinical Strategy for Rare Disease Therapeutics How bold trial designs, such as adaptive trials and basket trials testing one drug in several diseases, can help a first-of-its-kind therapy succeed. Panel Wed Nov 11 11:00–11:45 Capital with a Mission: Investing Beyond Traditional Venture Models How mission-driven and foundation investors fund neglected diseases such as glioblastoma and neuroblastoma that venture capital passes over, focusing on Switzerland. |
Find decision makers at Cellula Therapeutics
Tell us what you sell and we’ll find the people at Cellula Therapeutics most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction